SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending as the quantum computing sector gains momentum, fueled by management's guidance of strong revenue growth and IONQ's recent investor day. Community members are actively discussing the potential for a short squeeze given the high short interest, and some speculate about a possible big tech acquisition. QBTS is being compared to other quantum computing stocks like RGTI and IONQ, with some seeing it as undervalued.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending due to news of a significant $1.4 billion contract to build AI data centers, sparking excitement among investors. The community is discussing the potential for a short squeeze and the undervaluation of the stock relative to its market cap and revenue potential. Some investors are pointing to an upcoming event with Amazon as a further catalyst for the stock.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai ($BBAI) is trending as investors discuss its potential for a short squeeze, fueled by high short interest and heavy call option activity. Community members are pointing to institutional buying, particularly Goldman Sachs increasing its stake, and potential government contracts as catalysts. Some traders are also speculating about a rate cut and its impact on the stock, viewing it as a potential boost for the AI and defense-focused company.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending following news of a multi-year partnership with Google, including deeper integration with Google Cloud and AI. While some investors are excited about the potential for institutional investment and enhanced services, others are frustrated by the stock's lackluster price action despite the positive news. Community members are actively discussing whether this deal will be a game changer or if it's just another example of the stock's inability to react positively to news.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's stock is buzzing with activity as traders debate its current rally, especially ahead of the Fed's interest rate decision, with some anticipating a further surge while others foresee a pullback. Community discussions revolve around whether the stock can break through resistance levels and reach new highs, or if it's poised for a correction. Elon Musk's recent stock purchase and the company's AI advancements are also fueling the conversation amidst ongoing discussions of competition and market conditions.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as traders anticipate the Fed's rate decision and potential impact on tech stocks, with community debates focusing on whether rate cuts are already priced in and if Powell's comments will trigger a market shift. Discussions also revolve around the strength of the labor market and the potential for a market correction, even as some anticipate further gains.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is seeing volatile trading as the market digests the latest Fed decision and Powell's comments, leading to uncertainty about the near-term direction. Community members are actively debating whether this is a buying opportunity or a sign of further downside, with strong opinions on both sides. Many traders express frustration with perceived manipulation and the disconnect between market action and economic reality.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

IWM is experiencing volatile trading as the community debates its reaction to potential rate cuts and fluctuating economic data. Some traders anticipated a surge due to the expected cuts, while others believe the move is already priced in or foresee a "sell the news" event. Technical analysis and options flow are also being closely watched for directional clues.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as investors anticipate potential rate cuts following recent economic data and await upcoming CPI and PPI reports. Community discussions focus on whether the Fed will prioritize a weakening labor market over inflation risks, impacting bond yields. Some analysts suggest a buy for long-term holders.

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

MTEX is trending due to discussions around a potential pump and dump, with some users highlighting its low float and recent price movement. The community is debating whether the stock has a real catalyst for growth or if it's being manipulated, while others point to a past run and speculate about future price targets. Some traders are taking profits, while others express concerns about entering the stock at current levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Adverum Biotechnologies (ADVM) Receives a Buy from Oppenheimer

In a report released today, Francois Brisebois from Oppenheimer maintained a Buy rating on Adverum Biotechnologies (ADVM Research Report), with a...

Buy Rating for Adverum Biotechnologies Based on Promising Ixo-Vec Therapy and Strategic Growth Opportunities

TD Cowen analyst Joseph Thome has maintained their bullish stance on ADVM stock, giving a Buy rating on August 2. Joseph Thome has given his Buy ra...

Adverum Releases Interim Data From Gene Therapy Study For Blindness Disorder, Prepares For Pivotal Study

Adverum Biotechnologies presented 26-week interim data from the LUNA Phase 2 trial for Ixo-vec in wet AMD. The analysis showed significant reductions in anti-VEGF injections and positive visual...

Shares of 4D Molecular Therapeutics Inc. (FDMT) plummeted over 35% to $17.30 by Wednesday afternoon, marking it as the top loser among U.S. stocks. Surprisingly, retail traders remain highly bullish on the stock, with Stocktwits sentiment extremely bullish (85/100) amid extremely high message volumes (95/100).<figure class="image"><img style="aspect-ratio:1308/308;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/FDMT_Sentiment_Meter_On_Jul_17_5f2f85024d.png" alt="FDMT Stocktwits Sentiment Meter On Jul 17" width="1308" height="308"><figcaption>FDMT Stocktwits Sentiment Meter On Jul 17</figcaption></figure>Initially, FDMT shares climbed following the release of encouraging mid-stage clinical study results for its 4D-150 gene therapy, aimed at treating wet age-related macular degeneration (wAMD), a chronic eye disorder that leads to blurred vision or blind spots in central vision.However, the broader market turned its focus to various downside risks, including safety concerns raised by RBC Capital. While the firm maintains 4D-150 is "best in class," it flagged a "safety blip" – one case of inflammation in a patient with a history of syphilis, Investing.com <a href="https://in.investing.com/news/stock-market-news/4d-molecular-therapeutics-tumbles-following-midstage-clinical-study-results-432SI-4316187">reported</a>. BMO Capital lowering the price target further may have added to the pressure.Despite the sell-off, retail investors on Stocktwits seem to view Wednesday’s crash as a buying opportunity. One user noted that 4D’s peers, Ocular Therapeutix Inc. (OCUL), Adverum Biotechnologies Inc (ADVM) and EyePoint Pharmaceuticals Inc. (EYPT), “are taking it on the chin today.”“Obviously, Nasdaq taking it hard today as well. &nbsp;Perhaps, just a general opinion of overvaluation and market fatigue? &nbsp;Very odd stock movement to me, I do expect it will reverse soon,” said Stocktwits user ‘<a href="https://stocktwits.com/ehschunk/message/579821570">ehschunk</a>’.<figure class="image"><img style="aspect-ratio:1318/454;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/FDMT_stocktwits_comment_Jul_17_88b7f49b68.png" alt="Stocktwits user ehschunk's post on FDMT stream" width="1318" height="454"><figcaption>Stocktwits user ehschunk's post on FDMT stream</figcaption></figure>The overall market sentiment didn’t help, as U.S. stocks pulled back from their all-time highs on Wednesday, impacted by falling chip and tech stocks, though the Dow Jones managed its sixth consecutive day of gains.FDMT shares are down over 19% year-to-date, contrasting with OCUL’s impressive 65% rise. EYPT has had an even tougher year, losing 57% so far, while ADVM has lost only 0.18%.However, FDMT’s consistent performance in beating EPS estimates for the past four quarters provides some relief and hope for a rebound among its retail investors.

Wall Street’s Top Loser Today Stays In Retail’s Good Books: Stocktwits Extremely Bullish On FDMT

Despite a 35% drop in shares, retail investors remain bullish on 4D Molecular Therapeutics

Wall Street’s Top Loser Today Remains In Retail’s Good Books

Equity

Despite a 35% drop in shares, retail investors remain bullish on 4D Molecular Therapeutics on promising clinical study results

Adverum Biotechnologies (ADVM, $13.89) Aroon Indicator entered a Downtrend on April 01, 2024.

For the last three days, A.I.dvisor has detected that ADVM's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Short Interest Update

Adverum Biotechnologies, Inc. (NASDAQ:ADVM  Get Free Report) saw a significant decline in short interest in March. As of March 15th, there was short interest totalling 648,500 shares, a...

Adverum Biotechnologies (ADVM, $14.09) Aroon Indicator entered a Downtrend on March 28, 2024.

Adverum Biotechnologies (ADVM, $14.67) Aroon Indicator entered a Downtrend on March 27, 2024.

Adverum Biotechnologies (ADVM, $14.14) Aroon Indicator entered a Downtrend on March 26, 2024.

Adverum Biotechnologies (NASDAQ:ADVM) Upgraded to Hold at StockNews.com

Adverum Biotechnologies (NASDAQ:ADVM  Get Free Report) was upgraded by research analysts at StockNews.com from a sell rating to a hold rating in a research note...

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.

Adverum Biotechnologies Inc

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$1.68	--	--	N/A
Q2 '25	-$2.25	-$2.34	-4.15%	MISSED
Q1 '25	-$1.94	-$2.25	-15.98%	MISSED
Q4 '24	-$1.41	-$1.96	-38.54%	MISSED
Q3 '24	-$1.31	-$1.30	0.55%	BEAT

ADVM
Adverum Biotechnologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest ADVM News

ADVM Adverum Biotechnologies Inc